The Hung lab combines chemical and genomic approaches to define host–pathogen interactions and to reveal essential in vivo gene functions of pathogens that may be potential therapeutic targets for antimicrobial development. By deploying small organic molecules on a genome-wide scale to perturb and understand bacterial infection, we seek to identify new therapeutic prospects for a variety of devastating pathogens.